GLOW + KPV. Anti-inflammatory boost.
KLOW extends the GLOW formula with KPV*, a tripeptide fragment of α-melanocyte-stimulating hormone (α-MSH). Preclinical research has explored KPV for anti-inflammatory activity, particularly in the context of intestinal and dermal inflammation.
The stack is designed for operators whose recovery load is inflammatory as well as structural — post-training systemic inflammation, chronic dermal irritation, or gut-adjacent repair. Stacking KPV with BPC-157, TB-500, and GHK-Cu creates a 4-peptide protocol* in a single reconstitution.
At 80 mg total peptide* per vial, KLOW is the highest-strength formulation in the skin + healing category.
Every lot ships with an independent Certificate of Analysis on file. Below is the format your lot's COA arrives in — HPLC chromatogram, identity, endotoxin, the works. Request the document for the exact lot you receive.
request your lot's coa →“Higher concentration than GLOW, packaging was the same standard. KPV inclusion is the differentiator — vitalitiRX is one of the few Canadian sources that publishes COA data on multi-peptide blends including KPV.”
“Ordered after running GLOW for two cycles. Stepped up to KLOW for a stronger formula. Same vial quality, same lot-traceability process, same documentation.”
“The 80mg size means fewer reconstitutions across a longer research window. Packaging was solid. Wish the product page detailed the KPV component a bit more — had to dig through the FAQ to find the source publication.”
reviews describe product + service only — purity, packaging, lot traceability, fulfilment, COA access. per health canada guidance, claims about diagnosis, treatment, or specific outcomes are edited out before publication.
Research use only. Not for human consumption. Not approved by Health Canada for therapeutic use.

The copper peptide that declines with age.

Three peptides, one protocol.